Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

141 ARTÍCULOS , VIENDO DEL 61 AL 75

Development of Alzheimer-disease neuroimaging-biomarkers using mouse models with amyloid-precursor protein-transgene expression

Teipel SJ, Buchert R, Thome J, Hampel H, Pahnke J.

Prog Neurobiol. 2011 Dec;95(4):547-56. doi: 10.1016/j.pneurobio.2011.05.004. Epub 2011 May 12.

Molecular targets in the rational design of AD specific PET tracers: tau or amyloid aggregates?

Rojo LE, Gaspar PA, Maccioni RB.

Curr Alzheimer Res. 2011 Sep;8(6):652-8. doi: 10.2174/156720511796717203.

The concept of FDG-PET endophenotype in Alzheimer's disease

During EH, Osorio RS, Elahi FM, Mosconi L, de Leon MJ.

Neurol Sci. 2011 Aug;32(4):559-69. doi: 10.1007/s10072-011-0633-1. Epub 2011 Jun 1.

Gene expression profiling of peripheral blood leukocytes identifies and validates ABCB1 as a novel biomarker for Alzheimer's disease

Chen KD, Chang PT, Ping YH, Lee HC, Yeh CW, Wang PN.

Neurobiol Dis. 2011 Sep;43(3):698-705. doi: 10.1016/j.nbd.2011.05.023. Epub 2011 Jun 6.

Treat Alzheimer disease before it is symptomatic

Rosenberg RN.

Arch Neurol. 2011 Oct;68(10):1237-8. doi: 10.1001/archneurol.2011.135. Epub 2011 Jun 13.

Biomarkers and gene mutations as aids for detecting AD early

Grandy JK.

JAAPA. 2011 Jun;24(6):56-7. doi: 10.1097/01720610-201106000-00011.

Is hyperhomocysteinemia an Alzheimer's disease (AD) risk factor, an AD marker, or neither?

Zhuo JM, Wang H, Praticò D.

Trends Pharmacol Sci. 2011 Sep;32(9):562-71. doi: 10.1016/j.tips.2011.05.003. Epub 2011 Jun 20.

Review and meta-analysis of biomarkers and diagnostic imaging in Alzheimer's disease

Bloudek LM, Spackman DE, Blankenburg M, Sullivan SD.

J Alzheimers Dis. 2011;26(4):627-45. doi: 10.3233/JAD-2011-110458.

Amyloid-β protein precursor family members: a review from homology to biological function

Huang HC, Jiang ZF.

J Alzheimers Dis. 2011;26(4):607-26. doi: 10.3233/JAD-2011-110335.

Meta-analysis of plasma amyloid-β levels in Alzheimer's disease

Song F, Poljak A, Valenzuela M, Mayeux R, Smythe GA, Sachdev PS.

J Alzheimers Dis. 2011;26(2):365-75. doi: 10.3233/JAD-2011-101977.

Cerebrospinal fluid biomarkers for Alzheimer's disease: the present and the future

Ghidoni R, Benussi L, Paterlini A, Albertini V, Binetti G, Emanuele E.

Neurodegener Dis. 2011;8(6):413-20. doi: 10.1159/000327756. Epub 2011 Jun 25.

Functional magnetic resonance imaging as a dynamic candidate biomarker for Alzheimer's disease

Prvulovic D, Bokde AL, Faltraco F, Hampel H.

Prog Neurobiol. 2011 Dec;95(4):557-69. doi: 10.1016/j.pneurobio.2011.05.008. Epub 2011 Jun 22.

Novel aβ isoforms in Alzheimer's disease - their role in diagnosis and treatment

Portelius E, Mattsson N, Andreasson U, Blennow K, Zetterberg H.

Curr Pharm Des. 2011;17(25):2594-602. doi: 10.2174/138161211797416039.

The MTHFD1L gene rs11754661 marker is associated with susceptibility to Alzheimer's disease in the Chinese Han population

Ren RJ, Wang LL, Fang R, Liu LH, Wang Y, Tang HD, Deng YL, Xu W, Wang G, Chen SD.

J Neurol Sci. 2011 Sep 15;308(1-2):32-4. doi: 10.1016/j.jns.2011.06.036. Epub 2011 Jul 8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias